Last reviewed · How we verify

Tylenol and Ibuprofen only — Competitive Intelligence Brief

Tylenol and Ibuprofen only (Tylenol and Ibuprofen only) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Analgesic/Antipyretic combination (acetaminophen + NSAID). Area: Pain Management.

marketed Analgesic/Antipyretic combination (acetaminophen + NSAID) Prostaglandin synthesis pathway; COX-1 and COX-2 enzymes Pain Management Small molecule Live · refreshed every 30 min

Target snapshot

Tylenol and Ibuprofen only (Tylenol and Ibuprofen only) — The Cooper Health System. Acetaminophen reduces pain and fever by inhibiting prostaglandin synthesis in the central nervous system, while ibuprofen reduces pain, fever, and inflammation by inhibiting cyclooxygenase (COX) enzymes peripherally and centrally.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Tylenol and Ibuprofen only TARGET Tylenol and Ibuprofen only The Cooper Health System marketed Analgesic/Antipyretic combination (acetaminophen + NSAID) Prostaglandin synthesis pathway; COX-1 and COX-2 enzymes

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Analgesic/Antipyretic combination (acetaminophen + NSAID) class)

  1. The Cooper Health System · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Tylenol and Ibuprofen only — Competitive Intelligence Brief. https://druglandscape.com/ci/tylenol-and-ibuprofen-only. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators: